Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.10−0.20 (-0.86%)
Close on Nov 17, 2026Market cap $462.26MP/E –Yield –
Neurogene price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Neurogene's price to book ratio was 1.8× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.6× to 14.4×, with a median of 2.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | +0.7 |
| 2025 | Dec 31, 2025 | 1.1× | −1.0 |
| 2024 | Dec 31, 2024 | 2.2× | +1.2 |
| 2023 | Jan 31, 2023 | 1.0× | +0.1 |
| 2022 | Dec 30, 2022 | 0.8× | −4.5 |
| 2021 | Dec 31, 2021 | 5.3× | −6.5 |
| 2020 | Dec 31, 2020 | 11.8× | −8.9 |
| 2019 | Dec 31, 2019 | 20.7× | +18.1 |
| 2018 | Dec 31, 2018 | 2.7× | −7.0 |
| 2017 | Dec 29, 2017 | 9.7× | −0.3 |
| 2016 | Dec 30, 2016 | 10.0× | +2.4 |
| 2015 | Dec 31, 2015 | 7.5× | +3.3 |
| 2014 | Dec 31, 2014 | 4.2× | – |
See a number that looks wrong?